Advertisement
Pharma/Biotech News
Subscribe to Pharma/Biotech News
View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Roche Announces FDA Approval of Ovarian Cancer Treatment

November 17, 2014 1:30 pm | News | Comments

The FDA approves Roche's ovarian cancer treatment. Read more...                                 

Genzyme's MS Drug Gains FDA Approval

November 17, 2014 12:56 pm | News | Comments

The FDA approved Genzyme's new drug for the treatment of multiple sclerosis. Read more...                             

Study Lifts Cloud Over Heart Drugs

November 17, 2014 12:25 pm | by Marilynn Marchione - AP Chief Medical Writer | News | Comments

A major study lifts a cloud around blockbuster drugs for lowering cholesterol. Read more...                             

Advertisement

Eisai's Antiepileptic Treatment Receives Russian Approval

November 17, 2014 10:34 am | News | Comments

Eisai Pharmaceuticals announces Russian approval of antiepileptic treatment. Read more...                             

FDA Accepts Janssen's Schizoaffective Disorder Drug sNDA

November 14, 2014 12:11 pm | News | Comments

Janssen Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Applications (sNDAs) for the once-monthly atypical long-acting antipsychotic Invega Sustenna (paliperidone palmitate) to treat schizoaffective disorder as either monotherapy or adjunctive therapy. Read more...

FDA Accepts Actavis' Bipolar Drug sNDA

November 14, 2014 10:22 am | News | Comments

Actavis announced that the FDA accepted an application for bipolar disorder treatment in pediatric patients. Read more...                       

Roche Teams Up with LabCentral to Support Biotech Startups

November 13, 2014 12:27 pm | News | Comments

LabCentral and Roche announced an agreement in which Roche would provide technology and financial support to LabCentral, a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. Read more...

Abivax to Commercialize Vaccines in Asia, Latin America

November 13, 2014 10:05 am | News | Comments

Abivax, a leading European, clinical stage biopharmaceutical company developing and commercializing anti-viral compounds and human vaccines, announced that it has signed an agreement with The Finlay Institute, Havana, Cuba, that will allow it to commercialize vaccines against typhoid, meningococcus, and leptospirosis, in Asian and Latin American markets. Read more...

Advertisement

AstraZeneca, Isis Pharmaceuticals to Co-Develop Targeted Delivery

November 13, 2014 9:57 am | News | Comments

Isis Pharmaceuticals Inc. and AstraZeneca announced a strategic alliance to discover and develop novel delivery methods for antisense oligonucleotides. The new delivery approaches seek to target the desired tissue more effectively. Read more...                   

Gene Study Boosts Interest in Heart Drug Zetia

November 13, 2014 9:50 am | by Marilynn Marchione, AP Chief Medical Writer - Associated Press | News | Comments

Scientists have discovered gene mutations that give people naturally lower cholesterol levels and cut their risk of heart disease in half. That discovery may have a big implication. Read more...

Improved Survival in Women with HER2 Negative Breast Cancer

November 13, 2014 9:22 am | News | Comments

The results from a pooled analysis of two Phase 3 Halaven (eribulin) trials are published in Breast Cancer Research and Treatment. Findings from the pooled analysis show that eribulin improves overall survival in women compared to control. Read more...

The Odd Ouster of Sanofi's Former CEO

November 12, 2014 2:16 pm | by Ryan Bushey, Associate Editor | Articles | Comments

This high-flying pharma executive had his career derailed for a variety of surprising factors. Read more...                          

Abbvie's Hep C Therapy Shows Strong Cure Rate

November 12, 2014 10:37 am | News | Comments

AbbVie announced positive results for its therapy for chronic hepatitis C patients and liver transplant recipients. Read more...                     

Advertisement

Enterome, AbbVie to Collaborate on Treatments for Crohn's Disease

November 12, 2014 10:16 am | News | Comments

Enterome Bioscience and AbbVie will work together to develop solutions for the treatment of Crohn's disease. Read more...                       

Amgen and AstraZeneca's Psoriasis Drug Receives Positive Results

November 12, 2014 9:57 am | News | Comments

This drug is intended for patients with moderate-to-severe plaque psoriasis. Read more...                             

RA Drugs May Promote Vascular Health

November 11, 2014 12:49 pm | News | Comments

HemoShear, a discovery stage biotechnology company, and Janssen will report data showing that a subset of compounds used to treat RA also suppress inflammation and have the potential to promote vascular health. Read more...

OSU Professor Helps Develop Promising Ebola Drug

November 11, 2014 10:39 am | News | Comments

As the Ebola crisis in Africa continues and concern ramps up in the United States, a pharmaceutical company with a Corvallis connection is ready to respond with a limited amount of a potentially promising new drug. Read more...

FDA Accepts Amgen's BLA for Cholesterol-Lowering Drug

November 11, 2014 10:27 am | News | Comments

Amgen announced that the U.S. Food and Drug Administration (FDA) has accepted for review Amgen's Biologics License Application (BLA) for evolocumab for the treatment of high cholesterol. Read more...

New Research Venture Aims to Lower Cost of Meds

November 11, 2014 10:22 am | News | Comments

Bath is the first institution outside the United States to receive funding from the US Food & Drugs Administration (FDA), for a major new research collaboration that will strive to open up the pharmaceutical drugs market and enable the design of better and cheaper medicines. Read more...

Gilead's Hep C Drug Gets Positive Results

November 11, 2014 10:09 am | News | Comments

Gilead Sciences Inc. announced results from several Phase 2 and Phase 3 studies evaluating investigational uses of Harvoni (ledipasvir 90 mg/sofosbuvir 400 mg) for the treatment of chronic hepatitis C virus (HCV) infection in patients with limited or no treatment options. Read more...

BI Launches Global Trial for Antidote in Patients Taking Pradaxa

November 10, 2014 2:14 pm | News | Comments

Boehringer Ingelheim announced the initiation of U.S. sites for a test trial revolving around a potential antidote for patients taking pradaxa. Read more...                  

Dendreon Corporation Files for Bankruptcy

November 10, 2014 1:37 pm | by Tom Murphy - AP Business Writer | News | Comments

The company had high hopes for an innovative prostate cancer treatment but sales of the drug fell extremely short of expectations. Read more...                    

Lilly's Injectable Diabetes Drug is Now Available in US Pharmacies

November 10, 2014 1:18 pm | News | Comments

Eli Lilly's new type 2 diabetes drug arrives in US pharmacies today. Read more...                              

J&J Announces Completed Acquisition of Alios BioPharma

November 10, 2014 12:54 pm | News | Comments

Johnson & Johnson announced the completion of the acquisition of Alios BioPharma. Read more...                           

Encycle Therapeutics to Develop Molecule to Tackle IBD

November 10, 2014 10:54 am | News | Comments

Encycle Therapeutics is working a lead molecule to combat inflammatory bowel disease. Read more...                           

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading